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Ad-5Adeno-associated virus (AAV-2) replicates to high titers when host cells are coinfected with a helper virus.
Here we analyzed the coinfection of AAV-2 and mouse adenovirus (MAV-1) in murine ﬁbroblasts. We
observed that AAV-2/MAV-1 coinfected NIH 3T3 cells produced approximately 10–40-fold less AAV-2 DNAse
resistant particles than Hela cells. Levels of AAV-2 DNA replication were approximately 30-fold less in 3T3
cells as compared to Hela cells coinfected with human adenovirus (Ad-5). A study of these lower levels of
infection in 3T3 cells compared to Hela cells revealed that receptor binding and internalization of AAV-2 in
3T3 and Hela cells was comparable. However, AAV-2 did not enter into the nucleus of mouse cells as
efﬁciently as it does in human cells. Furthermore, viral DNA replication levels of AAV-2 DNAwere found to be
lower in mouse cells than human cells, indicating limitations in the murine nucleus for viral replication.
© 2009 Elsevier Inc. All rights reserved.IntroductionAdeno Associated Virus (AAV) is a non-pathogenic, single-stranded
DNA parvovirus. It has been classiﬁed in the genus Dependovirus
because it needs a helper virus for productive replication (Atchison
et al., 1965). The most common helper virus for AAV-2 is adenovirus
(Ad) (Hoggan et al., 1966) however human cytomegalovirus (CMV)
(McPherson et al., 1985), Herpes Simplex Virus (HSV) (Buller et al.,
1981) and Human Papilloma Virus (HPV) (Walz et al., 1997) also
provide helper functions. In the absence of helper virus, AAV-2
establishes a latent infection (Cheung et al., 1980) by preferential
integration in the long arm of chromosome 19 (Kotin and Berns, 1989;
Kotin et al., 1992; Samulski et al., 1991) at a site known as AAVS1. A
34 bp sequence (Giraud et al., 1994; Linden et al., 1996) located in the
ﬁrst exon of the myosin binding subunit 85 of protein phosphatase 1
has been shown to be the minimal AAVS1 element required to target
AAV-2 DNA at this chromosomal position. Helper virus infection can
rescue integrated AAV-2DNA from this site for a productive replication
of AAV. During coinfection, adenovirus early gene products facilitate
AAV-2 DNA replication, transcription and translation (Chang et al.,
1989; Grifman et al., 1999; Samulski and Shenk, 1988).
AAV serotype 2 (AAV-2) has a single-stranded DNA genome which
is 4780 nucleotide long (Srivastava et al., 1983). Both ends of the AAV-
2 genome has a 145 nucleotide long inverted terminal repeat (ITR)
(Lusby et al., 1980) encoding the viral origin of replication (Senapathy
et al., 1984) and genome packaging signal. The AAV-2 genome has twoand Cancer Biology, Mail Stop
o, 3000 Arlington Ave., Toledo,
pe).
ll rights reserved.translational open reading frames (ORF). The right ORF encodes three
structural capsid proteins as a result of alternative splicing (VP1, VP2,
and VP3) (Tratschin et al., 1984; Trempe and Carter, 1988) and the left
ORF encodes four non-structural proteins (Rep78, Rep68, Rep52, and
Rep40) (Mendelson et al., 1986). The RepmRNAs are under the control
of transcriptional promoters at map unit 5 and 19 (p5 and p19)
whereas Cap mRNAs are under the control of a transcriptional
promoter at map unit 40 (p40) (Hermonat et al., 1984). Rep proteins
have pleiotropic effects in the life cycle of AAV-2 regulating DNA
replication as well as RNA transcription (Labow et al., 1986; Tratschin
et al., 1986) both positively and negatively (Beaton et al., 1989).
Although AAV-2 is considered to be non-pathogenic it inhibits
proliferation of transformed cells (Batchu et al., 1999), and represses
transformation of mouse ﬁbroblasts by heterologous oncogenes
(Khleif et al., 1991). AAV-2 infection inhibits cell-cycle progression
(Berthet et al., 2005), causes cell death in p53 negative cells (Raj et al.,
2001), promotes differentiation and alters expression of several cell-
cycle regulated (Winocour et al., 1988) genes. Effects of AAV-2
replication are not limited to the host cell alone; AAV-2 also inhibits
replication of its helper viruses. During coinfection AAV-2 decreases
adenovirus DNA replication 2–20-fold (Jing et al., 2001; Timpe et al.,
2006). AAV-2 also decreases adenovirus cytotoxicity and production
in cell culture. In animal studies of AAV infection, AAV-1 was detected
in kidneys and lungs of fetuses and newborns, when pregnant mice
were injected subcutaneously with AAV-1 and murine adenovirus
(Lipps and Mayor, 1980). However, mice carrying AAV-1 acquired via
the transplacental route were protected against lethal infection by
MAV (Lipps and Mayor, 1982).
Productive AAV infections occur in awide range of cells and tissues
from a variety of species. However, a large number of non-permissive
cell types have also been identiﬁed (Bartlett et al., 1999; Girod et al.,
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1996). Even in cells that allow infection, the level of infection differs. A
wide range of factors can inﬂuence successful infection/transduction
of AAV-2 in target cells. For example, cells must ﬁrst express AAV
receptors and co-receptors on their surface for efﬁcient binding of the
virus. Heparan sulfate proteoglycan has been identiﬁed as the main
receptor for AAV-2 (Summerford and Samulski, 1998). In addition
ﬁbroblast growth factor receptor 1 (FGFR) (Qing et al., 1999) and αvβ5
(Summerford et al., 1999) have been proposed to be co-receptors
required for internalization of virus. After binding, the virus enters the
cell via clathrin coated vesicles (Bartlett et al., 2000), is transported to
the nucleus (Sanlioglu et al., 2000) and uncoated. The released single-
stranded genome of AAV undergoes second-strand synthesis to yield a
transcriptionally competent genome (Ferrari et al., 1996; Fisher et al.,
1996). Impediments at any of these stages may lead to a decreased
infection/transduction efﬁcacy of AAV.
As a prelude to studying replication of AAV-2 in a mousemodel we
analyzed the dynamics of AAV-2 infection in murine ﬁbroblasts with
helper functions provided byMAV-1. We observed that the replication
of AAV-2 in the presence of MAV-1 is up to 40-fold less in NIH 3T3 cells
as compared to replication in Ad-5 infected Hela cells. Although the
receptor binding of AAV-2 for both cell lines seems comparable, the
decreased replication of AAV-2 in 3T3 cells was due to the inefﬁcient
transport of AAV-2 from the plasmamembrane to the nucleus because
AAV-2 particles were observed in the perinuclear space and AAV-2
DNA was detected in cytosolic fraction after infection.
Results
AAV-2 DNAse I resistant particle production from NIH 3T3 cells versus
Hela cells
There have been few studies to analyze replication of wild type
AAV-2 in murine cells with helper functions provided by mouse
adenovirus. We determined if AAV-2 DNAse resistant particle (DRP)
were produced after coinfection of murine ﬁbroblasts with AAV-2 and
MAV-1. We chose NIH-3T3 cells as a model murine cell line and
compared the amount of DRP produced from these cells to that
produced by Hela cells. To this end, equivalent numbers of 3T3 and
Hela cells were coinfectedwith 500MOI of AAV-2 and 5MOI of MAV-1
or Ad-5, respectively. Hela cells were harvested 48 h post-infection
whereas 3T3 cells were harvested 48, 72 and 96 h post-infection.
As demonstrated in Fig. 1 at 48 h post-infection there was a
negligible number of AAV-2 DRPs produced from 3T3 cells. After 72 hFig. 1. AAV-2 DRP produced from 3T3 and Hela cells. Equivalent numbers of 3T3 and
Hela cells were coinfected with 500 MOI of AAV-2 and 5 MOI of MAV-1 or Ad-5
respectively. Crude AAV-2 extracts were prepared at the indicated times and real time
PCR was performed to determine AAV-2 DRPs produced per cell. Error bars represent
the standard deviations from mean of replicate PCR reactions.the number of AAV-2 DRPs from 3T3 cells was approximately 40-fold
less than the amount produced from Hela cells after 48 h. After 96 h,
the number of particles produced from 3T3 cells was approximately
10-fold less than those produced by Hela cells at 48 h. Hela cells
demonstrated extensive cytopathic effects at MOI 5 of Ad-5 after 48 h,
hence, the infections were stopped after 48 h to determine the
number of AAV-2 DRP. After 96 h the cytopathic effect in 3T3 cells due
toMAV-1 at MOI 5 was comparable to Ad-5 induced cytopathic effects
in Hela cells 48 h post-infection. Since the temporal progression of
MAV-1 infection appeared to be more prolonged than Ad-5 infection
we performed time course infections in 3T3 and Hela cells and
measured cytoxicity using MTT assays. This experiment veriﬁed that
Ad-5 infections in Hela cells progress more rapidly than MAV-1
infections in 3T3 cells. The level of Ad-5 induced cytoxicity in Hela
cells at 24 h was comparable to that observed in MAV-1 infected 3T3
cells at 48 h (data not shown). Therefore these conditions were used
for subsequent experiments unless indicated otherwise.
Replication of AAV-2 DNA in NIH-3T3 and Hela cells
The dramatic difference between the AAV-2 particle numbers
produced from3T3 cells compared to that of AAV-2 particles produced
from Hela cells at comparable points of cytopathic effect prompted us
to determine if AAV-2 DNA replication in 3T3 cells with help provided
by MAV-1 is equivalent to that AAV-2 DNA replication in Hela cells
with help provided by Ad-5. Comparable numbers of 3T3 or Hela cells
were coinfected with increasingMOI of AAV-2 (0.1, 1, 10, 100, and 500)
and 5 MOI of MAV-1 or Ad-5, respectively. 3T3 or Hela cells were
harvested 48 or 24 h later, respectively, low molecular weight AAV-2
DNA was extracted and analyzed by Southern hybridization. This
experiment revealed that MAV-1 was able to provide helper functions
for AAV-2 DNA replication in 3T3 cells, because replicative forms of
AAV-2 DNA were observed at AAV MOI of 10, 100 and 500 (Fig. 2a).
However, replicative form DNA was detected in Hela cells even at the
MOI of 0.1 (Fig. 2b). The replication signal was approximately 2–200-
fold lower in 3T3 cells compared to Hela cells as determined by
phosphor-imager analysis (data not shown) depending on the MOI of
AAV-2.
To obtain a more quantitative assessment of the difference in
replication of AAV-2 between 3T3 cells and Hela cells we determined
AAV-2 genome copy numbers per cell line after coinfection with AAV-
2 andMAV-1 or Ad-5. To this end, we coinfected 3T3 or Hela cells with
increasing MOI of AAV-2 and 5 MOI of MAV-1 or Ad-5. 3T3 and Hela
cells were harvested 48 h or 24 h later, respectively. Low molecular
weight AAV-2 DNAwas extracted and real time PCR was performed to
amplify AAV-2 DNA. As shown in Figs. 2c and d the number of AAV-2
genome copies per cell at the highest MOI in 3T3 cells was
approximately 30-fold less than the AAV genome copies in Hela
cells. This difference in DNA replication and genome copy number
corresponds to the differences noted in AAV-2 DRPs produced from
3T3 and Hela cells.
We also observed that L-929 murine ﬁbroblast cells supported
AAV-2 replication when coinfected with MAV-1 however the kinetics
of replication were even slower than replication of AAV-2 in 3T3 cells
(data not shown). These data demonstrate that AAV-2 DNA replicated
in murine cells with MAV-1 provided helper functions but the level of
replication was lower than that observed in Hela cells which are
highly permissive for AAV-2 infection.
Adenovirus replication in 3T3 and Hela cells
Previous observations prompted us to question if MAV-1 replicates
efﬁciently in 3T3 cells compared to the replication of Ad-5 in Hela
cells. To determine the replication levels of MAV-1 in 3T3 cells and the
replication of Ad-5 in Hela cells, equal numbers of 3T3 or Hela cells
were infected with 5 MOI of MAV-1 or Ad-5 respectively with or
Fig. 2. Replication of AAV-2 DNA in 3T3 and Hela cells. AAV-2 replicative form DNAwas detected after coinfecting (a) 3T3 and (b) Hela cells, with 0.1, 1, 10, 100 and 500 MOI of AAV in
lanes 3, 4, 5, 6 and 7 and 5 MOI MAV-1 or Ad–5, lanes 2–7, respectively. AAV DNA was analyzed by agarose gel electrophoresis and southern hybridization. Real time PCR was
performed to detect the replicative genome copy number of AAV DNA from (c) 3T3 and (d) Hela cells. Error bars represent the standard deviations from mean of replicate PCR
reactions. Data is representative of three independent experiments.
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and 24 h later respectively. Low molecular weight adenovirus DNA
was extracted and analyzed by Southern hybridization. As shown in
Fig. 3a we observed a robust replication of MAV-1 in 3T3 cells in the
absence of AAV-2. At the highest MOI (500) of AAV in coinfected 3T3
cells the levels of MAV-1 DNA replication seems to decrease by a
modest 2-fold as quantiﬁed by phosphor imager analysis (data not
shown). As expected Ad-5 DNA replication in Hela cells was robust. In
agreement with previously published studies (Timpe et al., 2006) Ad-
5 DNA replication decreases with increasing MOI of AAV-2 (Fig. 3b).
Quantiﬁcation by phosphor imager analysis (data not shown)
revealed that Ad-5 DNA decreased by approximately 15-fold at the
highest MOI of AAV.
To directly compare the replication of MAV-1 in 3T3 and Ad-5 in
Hela cells and to determine the effect of AAV-2 on adenovirus DNA
replication we determined the genome copy number of adenovirus
DNA by real time PCR. 3T3 or Hela cells were infected with 5 MOI of
MAV-1 or Ad-5, respectively, and increasing MOI of AAV-2. Cells were
harvested 48 or 24 h later respectively, lowmolecular weight DNAwas
extracted and real time PCR was performed. As shown in Fig. 3d there
was only a slight difference in genome copy number of MAV-1 and Ad-
5 per cell in the absence of AAV-2. Further, with increasing MOI of
AAV-2, the Ad-5 genome copy number decreased approximately 16-
fold at the highestMOI of AAV. However, the effect of AAV-2 onMAV-1
replication was not as pronounced and showed a decrease of about 5-
fold at the highest MOI of AAV. These results show that MAV-1
replicates in 3T3 cells robustly and there was not much difference in
the replication of MAV-1 in 3T3 cells as compared to that of Ad-5 in
Hela cells. Ad-5 DNA replication decreases in the presence of AAV-2 as
expected, however, the decrease in MAV-1 replication is less
pronounced.
To determine if the number of 3T3 cells supporting MAV-1
replication is similar to the number of Hela cells supporting Ad-5
replication. 3T3 and Hela cells were plated in an 8 well chamber slide.
These cells were infected with 5 MOI of MAV-1 or Ad-5 respectively.Two hours post-infection cells were treated with 5 mM of bromo-
deoxyuridine (BrDU). Hela and 3T3 cells were ﬁxed 24 and 48 h later
respectively and immuno-stained for BrDU-substituted DNA. For
detecting the newly synthesized cellular DNA by BrDU incorporation
DNA needs to be denatured (Fox et al., 1991). However because
adenovirus DNA replicates by single-strand displacement mechanism
(Lechner and Kelly, 1977) thereby generating single-stranded DNA
hence denaturation of DNA is not required (Bosher et al., 1992). This
allows us to speciﬁcally detect adenoviral DNA replication by staining
for BrDU. As shown in Figs. 4a and c, we did not see any signal from
uninfected cells however BrDU stained cells were observed in Ad-5 or
MAV infected Hela or 3T3 cells, respectively (Figs. 4b and d). The
number of cells showing BrDU staining and therefore supporting
replication of MAV-1 or Ad-5, was comparable at approximately 8%.
These results showing comparable levels MAV-1 or Ad-5 DNA
replication indicate that the difference in the number of cells
supporting replication of adenovirus in 3T3 versus Hela cells is
probably not the reason for fewer AAV-2 DRPs produced or decreased
levels of AAV-2 DNA replication in 3T3 cells compared to Hela cells.
Availability of receptors, receptor avidity and internalization of AAV-2 in
3T3 cells and Hela cells
Our results suggest that lower levels of AAV-2 replication in 3T3
cells as compared to Hela cells may be due to inefﬁcient AAV-2
infection of 3T3 cells. This inefﬁciency of infection can be attributed to
(a) availability and binding of AAV to its receptor on the cell surface
(b) internalization of AAV (c) transport of AAV from the cell
membrane to the nucleus (d) AAV protein expression or (e) DNA
replication. We analyzed each of these steps during the infection of
AAV in 3T3 and Hela cell lines.
To determine if the number of receptors available for binding of
AAV-2 in 3T3 cells and Hela cells are comparable, we infected equal
numbers of cells with an MOI of 105 of AAV-2. A high MOI was used to
saturate the receptors available on the cell surface with AAV-2.
Fig. 3. Replication of MAV-1 and Ad-5 in 3T3 and Hela cells. (a) MAV-1 and (b) Ad-5
DNA replicationwas detected after coinfecting 3T3 or Hela cells with 5MOI of MAV-1 or
Ad-5 (lanes 2–7) respectively and with 0.1, 1, 10, 100 and 500MOI of AAV-2 in lanes 3, 4,
5, 6 and 7. Adenovirus DNA was extracted and analyzed by agarose gel electrophoresis
and southern hybridization. (c) Real time PCR was performed to compare the MAV-1
and Ad-5 genome copy number per cell with or without AAV-2. Error bars represent the
standard deviations from mean of replicate PCR reactions. Data is representative of
three independent experiments.
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internalization. One hour later, cells were washed extensively with
cold PBS on ice to remove any free virus. Cells were harvested and viral
DNA was extracted. Real time PCR of AAV-2 DNA was performed to
determine the number of AAV-2 particles bound per cell. As shown in
Fig. 5a the number of AAV-2 particles bound per cell was comparableFig. 4. BrDU staining to detect cells supporting MAV-1 and Ad-5 DNA replication. Ad-5 or MA
with BrDU. BrDU incorporation in viral DNA was detected by immunoﬂuorescence.in both 3T3 and Hela cells suggesting that initial virus interactionwith
receptors was similar in each cell type.
Next, we sought to determine if receptor binding of AAV-2 in 3T3
cells is similar to that of Hela cells. 3T3 and Hela cells were coinfected
with increasing MOI of AAV-2 and 5 MOI of MAV-1 or Ad-5,
respectively, in serum free medium. In this experiment, lower MOIs
for AAV-2 infection were used to mimic the conditions used for
analyzing AAV-2 DNA replication. Infections were conducted for 1 h at
4 °C to prevent internalization of virus. Viral DNA was extracted and
real time PCR of AAV DNAwas performed to determine the number of
AAV-2 particles bound per cell. As shown in Fig. 5b, the number of
AAV-2 particles bound per cell was comparable for both 3T3 and Hela
cells. This indicated that binding of AAV-2 for its receptor in 3T3 and
Hela cells was comparable.
Next we analyzed if the internalization of virus was different in the
cell lines. To this end 3T3 and Hela cells were coinfected with
increasing MOI of AAV-2 and 5 MOI of MAV-1 and Ad-5, respectively.
Cellswere incubated at 37 °C for 2 h followingwhich cellswerewashed
with PBS three times and trypsinized to remove any virus bound to the
receptors on cell surface. Viral DNA was extracted and real time PCR
was performed to detect the number of AAV-2 particles internalized.
Fig. 5c shows comparable number of particles internalized per cell for
both 3T3 and Hela cells. These results (Figs. 5a, b, and c) show that the
numberof available receptors, receptor binding and the internalization
of AAV-2 is comparable in both 3T3 and Hela cells. Thus AAV-2 gains
entry into both the cell lines with comparable efﬁciency.
AAV-2 protein expression in 3T3 and Hela cells
Observing a comparable number of AAV-2 particles bound to the
receptors and internalized in both 3T3 and Hela cells we wanted to
conﬁrm if AAV Rep and Cap proteins were expressed in 3T3 cells to
support AAV-2 DNA replication and packaging. 3T3 cells were
coinfected with 10 or 100 MOI of AAV-2 and 5 MOI of MAV-1. Cells
were harvested 48 h post-infection and nuclear extracts were
prepared, separated by SDS-PAGE electrophoresis and proteins were
transferred to a nitrocellulose membrane and probed for AAV-2 Rep
and Cap proteins. As shown in Fig. 6a, all of the Rep and Cap proteins of
AAV-2 were expressed in coinfected 3T3 cells. We also observed that
the abundance of Rep and Cap proteins from 3T3 cells was lower thanV-1 (a, c) uninfected or (b, d) infected Hela or 3T3 cells, respectively cells were treated
Fig. 5. Number of receptors, receptor avidity and internalization of AAV-2 in 3T3 and
Hela cells. Equivalent numbers of 3T3 and Hela cells were infected with (a) 105 MOI of
AAV-2 at 4 °C, (b) 1, 10, 100 and 500 MOI of AAV-2 at 4 °C, (c) 1, 10, 100 and 500 MOI at
37 °C. Cells were washed and real time PCR was performed to detect to number of AAV
genomes bound on the cell surface (a, b) or internalized in each cell line (c). Error bars
represent the standard deviations frommean of replicate PCR reactions. Infections were
done in triplicates.
Fig. 6. AAV-2 protein expression in 3T3 and Hela cells. 3T3 cells were infected with the
indicated MOI of AAV-2 and MAV-1. Nuclear extracts were prepared and separated by
SDS-PAGE and AAV Rep and Cap proteins were detected by western blotting (a). (b)
Hela or (c) 3T3 cells were infected with 500 MOI of AAV-2 and 5 MOI of MAV-1 or Ad-5
respectively. Cap proteins were detected by immunoﬂuorescence.
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replication in 3T3 cells.
To determine if there was a difference in the number of cells
supporting AAV protein expression between 3T3 and Hela cells, we
plated equal number of cells in an 8 well chamber slide. Cells were
then coinfected with increasing MOI of AAV-2 and 5 MOI of MAV-1 or
Ad-5, respectively. 3T3 and Hela cells were ﬁxed 48 or 24 h later,
respectively, and stained for Cap proteins. As shown in Figs. 6b and c
there was robust expression of Cap proteins in Hela cells however the
number of 3T3 cells showing Cap expression was much lower (data
shown for 500 MOI of AAV-2). The average of Cap-positive cells from
three independent experiments indicated that at 500 MOI of AAV-2
and 5 MOI of Ad-5 or MAV-1, the percentage of Cap-positive Hela cells
was approximately 12-fold higher than that of Cap-positive 3T3 cells.
Localization of Cap proteins in 3T3 and Hela cells
Having observed comparable numbers of AAV-2 particle bound to
the receptor, and internalized in 3T3 and Hela cells we next
determined if a difference in trafﬁcking of AAV-2 in either cell line
accounted for different levels of DNA replication and protein
expression of AAV-2 in 3T3 and Hela cells. 3T3 or Hela cells were
plated in 8 well chamber slides. Cells were coinfected with AAV-2 MOIof 10, 100 and 500 and 5 MOI of MAV-1 or Ad-5. Cells were ﬁxed 24 or
48 h post-infection and stained for Cap proteins in both cell lines. As
seen in Fig. 7a, we observed foci of Cap proteins in the nuclei of Hela
cells; a hallmark of Cap expression. However, in 3T3 cells we observed
the signal for Cap proteins in the peri-nuclear space Fig. 7b (results
shown only at the 500 MOI of AAV-2). The presence of AAV-2 Cap
protein in the peri-nuclear space suggests that it is input virus rather
than newly synthesized virus for two reasons; we see this signal only
with high MOI and that newly synthesized Cap expression is localized
exclusively in the nucleus. It has been demonstrated that phosphor-
ylation of the AAV-2 vectors at tyrosine residues directs them for
ubiquitination followed by proteosome mediated degradation (Zhong
et al., 2008). The absence of Cap signal in 3T3 cell at lowerMOIs can be
because of rapid ubiquitination followed by degradation of input viral
particles in 3T3 cells as compared to Hela cells.
To further conﬁrm the localization of AAV-2 DNA we infected 3T3
and Hela cells with 10 MOI of AAV-2 with or without adenovirus. Cells
were incubated with virus for 2 h at 37 °C. Cells were harvested and
nuclear and cytoplasmic fractions were separated. AAV-2 DNA was
ampliﬁed by PCR from both the fractions and separated by agarose gel
electrophoresis. As shown in Fig. 8 it is clear that AAV-2 DNA in Hela
cells was present exclusively in the nucleus bothwith andwithout Ad-
5. However, in 3T3 cells the majority of AAV-2 DNAwas present in the
cytoplasmic fraction. This observation is in agreement with Hansen
et al. (2000) wherein the majority of AAV-2 DNA was detected in the
cytosolic fraction in 3T3 cells as compared to Hela cells. In the
presence of MAV-1, AAV-2 DNA was detected in the cytoplasm even
though it is known that human adenovirus aids in the trafﬁcking of
AAV-2 from cell membrane to the nucleus (Xiao et al., 2002). As
mentioned earlier the lower levels of AAV-2 DNA in 3T3 cells as
compared to Hela cells may be due to rapid degradation of AAV-2
particles in them. These experiments suggest that there is a trafﬁcking
defect in 3T3 cells as compared to Hela cells for AAV-2. This defect
keeps AAV-2 in the cytosol in 3T3 cells thereby causing a decreased
replication of AAV-2 in 3T3 cells as compared to Hela cells, even in the
presence of adenovirus.
Fig. 7. Localization of Cap proteins in 3T3 and Hela cells. (a) Hela or (b) 3T3 cells
growing in chamber slides were coinfected with 500 MOI of AAV-2 and 5 MOI of MAV-1
or Ad-5, respectively. Cells were then immunologically stained for AAV-2 Cap proteins.
Fig. 9. AAV-2 protein expression after pNTC244 transfection in 3T3 and Hela cells.
(a) Hela or (b) 3T3 cells were transfected with pNTC244 and infected with Ad-5 or
MAV-1 respectively. 24 or 48 h later respectively cells were immunologically stained for
AAV Cap proteins.
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After observing a defect in AAV-2 trafﬁcking in 3T3 cells compared
to Hela cells we decided to analyze if the protein expression and DNA
replication of AAV were comparable in 3T3 and Hela cells when
transfected with a plasmid carrying the AAV-2 genome. This approach
bypasses the intracellular trafﬁcking of AAV-2 and allows us to directly
compare levels of AAV-2 replication. 3T3 or Hela cells were plated in
an 8 well chamber slide and transfected with pNTC244 and infected
withMAV-1 or Ad-5. 3T3 and Hela cells were ﬁxed and stained for Cap
proteins. As expected we observed Cap protein expression in
transfected cells, however the number of Cap-expressing 3T3 cells,
as shown in Figs. 9a and b, was much lower than Cap-expressing Hela
cells. This result shows that evenwithout a need for virus transport to
the nucleus the levels of AAV-2 proteins remain lower in 3T3 cells
compared to Hela cells.
AAV-2 DNA replication after plasmid transfection
To analyze if there was a difference in DNA replication between
3T3 and Hela cells, pNTC244 was transfected in the presence of
adenovirus and AAV-2 replication was determined by Southern
hybridization. To verify that equivalent transfection efﬁciency was
obtained for 3T3 and Hela cells, each cell line was transfected with a
GFP expressing plasmid. Twenty four hours post-transfection; both
cell lines showed a comparable number of green cells (approximately
30% data not shown). To further compare the transfection efﬁciency,
equal numbers of 3T3 and Hela cells were transfected with pNTC244.
6 h post-transfection cells, were harvested and low molecular weight
plasmid DNA was extracted. Extracted DNA was subjected to DpnI
treatment to remove input plasmid. The isolated DNA was then
analyzed by agarose gel electrophoresis and Southern hybridization.Fig. 8. Localization of AAV-2 DNA in 3T3 or Hela cells. 3T3 or Hela cells were infected
with 10 MOI of AAV-2 and 1 MOI of MAV-1 or Ad-5, respectively. Nuclear and cytosolic
extracts were separated and AAV-2 DNA ampliﬁed by PCR. Ampliﬁed DNA was after
agarose gel electrophoresis.Autoradiography revealed comparable levels of AAV-2 DNA from both
cell lines (data not shown). These experiments revealed that the
transfection efﬁciencies of both cell lines were comparable.
To analyze the replication efﬁcacy of AAV-2 DNA, equivalent
numbers of 3T3 and Hela cells were transfected with pNTC244. Three
hours after addition of DNA, cells were infected with 5 MOI of MAV-1
or Ad-5. 3T3 or Hela cells were harvested 48 or 24 h post-infection.
Low molecular weight viral DNA was extracted, subjected to DpnI
digestion to remove any free plasmid DNA, separated by agarose gel
electrophoresis and transferred to a nitrocellulose membrane. The
membrane was then probed for replicative forms of AAV-2 DNA using
a radio-labeled AAV-2 DNA fragment. As seen in Figs. 10a and b we
observed AAV-2 DNA replication in both Hela and 3T3 cell lines
respectively. However, replication of AAV-2 DNA in 3T3 cells was
approximately 5-fold less than the replication of AAV-2 in Hela cells.
This result indicates that alongwith having a defect in trafﬁcking there
was also a defect in replication of AAV-2 DNA in 3T3 cells. These
experiments indicate that AAV-2 is also defective for replication in 3T3
nuclei as compared to the Hela nuclei.
Discussion
Given the nature of the effects of AAV-2 on host cells and helper
virus, and due to the interest in the use of AAV-2 as a vector for geneFig.10. AAV-2 DNA replication after pNTC244 transfection in 3T3 and Hela cells. (a) Hela
or (b) 3T3 cells were transfected with pNTC244, infected with MAV-1 or Ad-5,
harvested 24 or 48 h, respectively. Viral DNAwas prepared and analyzed by agarose gel
electrophoresis and southern hybridization.
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virus in animal models be studied in detail. As a prelude to studying
the coinfection of AAV-2 and adenovirus in mice, we studied
coinfection of AAV-2 and MAV-1 in murine ﬁbroblasts and compared
it to AAV-2 replication in Hela cells with Ad-5 provided helper
functions. We observed that even after 96 h the number of AAV-2
particles produced from 3T3 cells was approximately 10-fold less than
the number of particles produced from Hela cells. Further, AAV DNA
replication in 3T3 cells was approximately 30-fold less than AAV DNA
replication in Hela cells even though the levels of MAV-1 and Ad-5
replication in 3T3 and Hela cells were comparable as detected by
Southern blotting, Real time PCR and BrDU incorporation.
It is well established that the transduction of rAAV vectors in
different cell types can be limited at multiple steps (Ding et al., 2005;
Sanlioglu et al., 2001). These include availability of the receptors or co-
receptors on the cell surface thereby allowing binding and inter-
nalization of virus, trafﬁcking from the cell membrane to the nucleus
(Bartlett et al., 2000; Duan et al., 2000) and conversion of single-
stranded AAV DNA to a transcriptionally active double-stranded
conformation (Ferrari et al., 1996; Fisher et al., 1996). We system-
atically analyzed if infection of wtAAV-2 in 3T3 cells is limited at one
or more of these stages and if coinfection of MAV-1 helps wtAAV-2 to
overcome these obstacles.
Infection of 3T3 and Hela cells 4 °C and 37 °C revealed that number
of wtAAV-2 particles binding on the cell surface and their internaliza-
tion is comparable for both cell lines. This data is in agreement with
previous studies (Qing et al., 1999) wherein it was observed that even
though rAAV vector could bind to both Hela and 3T3 cells efﬁciently,
the transduction in 3T3 cells was much lower than Hela cells. The
amount of binding detected in our assays is likely due to virus–
receptor interactions rather than non-speciﬁc binding to other areas
of the cell surface. Two published studies have shown that in the
absence of virus receptor or co-receptor in four different cell lines,
virus binding is dramatically reduced or negligible (Qing et al., 1999;
Summerford and Samulski, 1998). These experiments helped us rule
out the possibility of inefﬁcient AAV-2 receptor binding or inter-
nalization as a reason for the difference in the AAV DNA replication in
3T3 cells compared to Hela cells.
Observing similar levels of AAV-2 particles bound and internalized
in both Hela and 3T3 cells we questioned whether AAV-2 travels from
the cell membrane to the nucleus in 3T3 cells. As seen in Fig. 7b, 3T3
cells coinfected with MAV-1 and AAV-2 showed Cap staining in the
perinuclear region at the highest MOI. However, this was not the case
with Hela cells. PCR analysis for detecting AAV-2 DNA in nuclear
versus cytosolic fraction in each cell line showed that in 3T3 cells,
AAV-2 DNA remained in the cytosolic fraction. These results support
earlier observation (Hansen et al., 2000) that even 48 h after infection
of 3T3 cells with rAAV, the majority of vector DNA was in the
cytoplasmic fraction as compared to 293 cells that showed nuclear
localization. The observation of Cap signal in 3T3 cells only at the
higher MOI and lower levels of AAV-2 DNA may be explained by rapid
degradation of AAV particles in 3T3 cells as compared to Hela cells
(Zhong et al., 2008). We observed AAV-2 Cap signal in the cytosol up
to 48 h post-infection, even thoughwe had coinfected cells withMAV-
1. Adenovirus has been shown to help AAV-2 trafﬁc from cell
membrane to nucleus (Xiao et al., 2002).
Bypassing the trafﬁcking stage of AAV infection by transfection of
plasmid for wt AAV-2 genome did not allow the levels of AAV DNA
replication in 3T3 cells to be comparable to AAV-2 DNA levels in Hela
cells. This lower level of DNA replication in 3T3 cells could be due to
differences in the support provided by host nuclear factors in 3T3
versus Hela cells. These cellular differences may cause inefﬁcient
single-stranded to double-stranded conversion of genomes of inter-
nalized AAV-2 particles leading to decreased AAV-2 DNA replication.
These results indicate that the intracellular milieu in Hela cells is
more conducive for AAV-2 replication than 3T3 cells. It has beendemonstrated that processing of AAV-2 vectors is impaired in 3T3 cells
as compared to 293 cells (Hansen et al., 2001). It would be interesting
to observe whether endocytic processing of AAV-2 in 3T3 cells after
coinfection with MAV-1 gets altered and to identify the cytosolic
compartment in which AAV-2 is obstructed in 3T3 cells after
coinfection with MAV-1. Further, since EGFR inhibitors can increase
transduction by rAAV vectors in non-permissive cell lines by
phosphorylating ssDBP (Mah et al., 1998; Smith et al., 2003) it
would be interesting to determine if treatment with these chemical
agents increase AAV DNA replication in 3T3 cells. Previously it has
been observed that treatment of 3T3 cells (Qing et al., 1999) with
tyrphostin 1 did not increase transduction by rAAV-2 vector. We
would like to analyze the effects of EGFR inhibitors when 3T3 cells are
coinfected with wild type AAV-2 and MAV-1. It has been demon-
strated by Zhong et al. (2008) that tyrosine phosphorylation may lead
to proteosome mediated degradation of AAV particles. We have
observed Cap signal in 3T3 cells only at the higher MOI and lower
levels of AAV-2 DNA in 3T3 cells as compared to Hela cells. Hence, it
would be worth to observe if there is an increased phosphorylation of
AAV-2 capsid in 3T3 cells as compared to Hela cells thereby leading to
a rapid degradation of AAV-2 Cap in 3T3 cells.
These studies are an assessment of AAV replication in mouse
ﬁbroblast cells using MAV-1 as a helper virus. Our results indicate that
while there are some limitations to AAV replication, a full and
productive infection occurs in mouse cells. These results pave the way
for future investigations in whole animals as a rodent model of AAV
infection.
Materials and methods
Cells and viruses
Hela and mouse NIH 3T3 cells were grown in MEM and DMEM
respectively supplemented with 10% FBS, glutamine and antibiotics.
All cells were maintained as monolayer cultures at 37 °C in a 5% CO2
atmosphere.
Mouse adenovirus (MAV-1) was kindly provided by Dr. K.R.
Spindler (University of Michigan). MAV-1 was prepared by infection
of ﬁfteen 10-cm dishes of NIH 3T3 cells. 96 h later cells were harvested
by scraping in the medium and low speed centrifugation. Cells were
resuspended and lysed by 3 freeze–thaw cycles. The crude lysate was
cleared of cell debris by centrifugation at 10,000 rpm for 10min at 4 °C
and the supernatant containing the virus was saved. Physical particle
and infectious titer of MAV-1 was determined by real time PCR and
western blotting for MAV-1 E1A protein after limiting dilution
infection of 3T3 cells. Titer of Ad-5 was determined in Hela cells as
previously described (Winters and Russell, 1971).
AAV was prepared by transfecting 293 cells with pNTC244 plasmid
(Laughlin et al., 1983) and infecting them with Ad-5. 40 h later cells
were harvested, subjected to three freeze–thaw cycles, and treated
with DNase I. Extracts were fractionated by heparin-agarose column
chromatography and the infectious titer of AAV was determined by
dot blot analysis as described previously (Casper et al., 2005).
Infections and transfections
Ad-5 or MAV-1 were used at multiplicity of infection (MOI) 5 and
AAV-2 was used at the MOI indicated in the text and ﬁgure legends.
Cells were infected when they reached 90% conﬂuency. Infections
were performed in serum free medium for 2 h after which medium
was replaced with complete medium. Cells were plasmid transfected
at 90% conﬂuency using Lipofectamine 2000 (Invitrogen) in serum
free medium for 4 h according to manufacturer's recommendations.
The DNA to Lipofectamine 2000 ratio usedwas 1 μg:2.5 μl and 4 μgwas
transfected in 6 well plates. Four hours after transfection, mediumwas
replaced with complete medium.
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Genome copy numbers for AAV-2, Ad-5 and MAV-1 were
determined by quantitative real time PCR. The forward primer for
AAV-2 was 5′ AAC TGG TTC GCG GTC ACA A 3′ (AAV-2 nt 708) and the
reverse primer was ACC CGA CCA GCT CCA TGT AC (AAV-2 nt 1008).
These primers amplify a 301 base pair fragment. The forward primer
for MAV-1 was 5′ ATG TCG CGG CTC CTA CG 3′ and the reverse primer
was 5′ CAA CGA ACC ATA AAA AGA CAT CAT 3′. These primers amplify
a 512 base pair fragment of the MAV-1 E1A gene. Primers were used at
a ﬁnal concentration of 0.3 μM. Applied Biosystems Power Sybr-Green
master mix was used to perform PCR. Ampliﬁcation was performed at
95 °C for 10 min to activate the polymerase followed by 40 cycles at
95 °C for 30 s, 54 °C for 45 s and 72 °C for 45 s. Genome copy number
was determined by comparison to a standard curve plotted after
ampliﬁcation of the same fragment from plasmid pNTC244 or from a
MAV-1 E1A fragment cloned into pGEM-T (Promega) at 10 fold serial
dilutions from 1×1010 to 1×102 copies. All experimental and serial
dilution templates were run in triplicate. Data was analyzed using
7500 system SDS software (Applied Biosystems).
To determine AAV-2 DNAse resistant particles (DRP), crude viral
extracts were prepared from harvested cells by 3 freeze–thaw cycles
to lyse cells, DNAse I treatment for 30 min to remove any free viral
DNA followed by inhibition of DNAse I by heating extracts at 65 °C.
Viral DNA was extracted from these extracts and real time PCR was
performed to amplify AAV-2 DNA, which would result in the number
of DNAse resistant AAV-2 genomes produced per cell from both cell
lines.
Southern blot
Low molecular weight viral DNA was extracted from Hela and NIH
3T3 cells 24 or 48 h post-infection respectively using Qiagen QIAmp
DNA mini kit. DNA extracted after transfection was subjected to DpnI
digestion before electrophoresis to degrade unreplicated plasmid
DNA. Samples were subjected to RNase treatment and extracted DNA
was electrophoresed on a 1% agarose gel. After electrophoresis, the
DNAwas transferred to a NYTRAN membrane and hybridized to AAV-
2-, MAV-1- or Ad-5-speciﬁc radioactive probe. The membrane was
exposed to HyBlot Cl autoradiography ﬁlm. For quantiﬁcation of data
the membrane was exposed to a phosphor screen and the signal was
quantiﬁed using a Typhoon Phosphorimager and Image Quant
Software.
The plasmid pNTC244 was digested with HindIII and the resulting
AAV fragment was used as probe for radiolabeling. Ad-15 and MAV-1
probe were prepared by PCR ampliﬁcation. A 1.6 kb fragment
corresponding to Ad-5 nucleotide sequence 3828 to 5481 was
ampliﬁed and a 512 base pair E1A gene fragment was ampliﬁed
from MAV-1. These fragments were labeled according to the
manufacturer's recommendation (Random Primed DNA labeling kit)
(Roche).
Immunoﬂuorescence
1.5×104 Hela or 3T3 cells were plated in each well of a 8 well
chamber slide, 24 h before infection. Cells were infected and/or
transfected (1 μg per well) as described above. 24 or 48 h post-
infection or transfection, cells were ﬁxed and permeabilized with
100% cold methanol. Cells were then washed and blocked with 2%
bovine serum albumin (BSA) in PBS (Phosphate Buffer Saline). After
blocking the cells were treated with RIPA buffer for 10min (50mMTris
pH 8, 150 mM NaCl, 0.5% DOC, 0.1% SDS, 1% NP40) for cell lysis. Fixed
cells were incubated with primary antibody used at a dilution of 1:50
in BSA-PBS (afﬁnity puriﬁed rabbit anti-Cap (Trempe et al. unpub-
lished data), and 1:50 mouse anti-BrdU) for 1 h. Cap antibody used
detects both whole capsid as well as disassembled Cap proteins.Primary antibody was removed and cells were washed with BSA-PBS.
Cells were incubated with secondary antibody diluted in BSA-PBS
[1:200 donkey anti-rabbit (Molecular Probes) and anti-mouse
conjugated AlexaFlour488 (Molecular probes)] for 1 h followed by
washes with BSA-PBS. Slides were incubated for 5 min with 150 nM
DAPI (4′, 6-diamidino-2-phenylindole) to stain nuclei. Cells were
washed with BSA-PBS and then PBS alone to remove traces of DAPI.
The gasket was removed and the slide was covered with a layer of
DAKO Fluorescent Medium and a coverslip. A Nikon eclipse E 800
ﬂuorescent microscope was used for analysis of the stained cells.
Immunoblotting
Hela cells or 3T3 cells were harvested at 24 or 48 h post-infection,
respectively. For detecting expression of AAV-2 Rep, Cap and MAV-1
E1A proteins nuclear extracts were prepared. Infected cells were
scraped in medium, pelleted and washed with PBS+5mMMgCl2. Cell
pellets were resuspended in STM-NP buffer [10 mM Tris (pH8.0),
0.25 mM sucrose, 10 mM MgCl2, 0.5% NP40, 1 mM PMSF and 0.1 mM
DTT]. Cells were kept on ice for 15 min with intermittent vortexing.
Nuclei were pelleted by centrifugation at 2000 rpm for 5 min. The
supernatant (cytoplasmic fraction) was removed and pellets were
resuspended in IPP buffer [50 mM Tris, 150 mM NaCl, 20 mM EDTA
and 0.5% NP40 and 1 mM DTT supplemented with protease inhibitors
(1 mM PMSF, 1 μM leupeptin, 1 μg/ml pepstatin and 1 mM
benzamidine)]. Extracts were kept on ice for 1 h with intermittent
vortexing. After 1 h, extracts were centrifuged at high speed
(13000 rpm) for 5 min and the supernatant was saved. These nuclear
extracts were separated on a 12% SDS polyacrylamide gel and
transferred to a nitrocellulosemembrane. Themembranewas blocked
with 5% BSA in Tris Buffered saline containing 0.5% Tween 20 (TBST).
Rabbit anti E1A serum (provided by KR Spindler) diluted in 1% BSA-
TBST (1:3000) was used to probe for MAV E1A protein. AAV Rep and
Cap proteins were probed using afﬁnity puriﬁed rabbit anti-Rep
(Trempe et al., 1987) and anti-Cap antibody (unpublished data)
diluted in 0.5% BSA-TBST (1:3000). After 1° antibody treatment the
membrane was washed 3 times with TBST and the membrane was
then incubated with horse radish peroxidase (HRP) conjugated anti-
rabbit 2° antibody diluted in 0.5% BSA-TBST (1:10,000). Proteins were
detected by ECL reaction and exposure of membrane to HyBlot Cl
autoradiograhy ﬁlm.
Nuclear and cytosolic fractionation of infected Hela and 3T3 cells
Two hours post-infection 3T3 and Hela cells were harvested and
nuclear and cytosolic fractions to amplify AAV DNA were prepared as
described (Smith et al., 2003).
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